Telix Pharmaceuticals Limited has released a press release.
Sales Note to Accompany June 2019 Quarter Appendix 4C
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
Story so far
Earlier from Telix Pharmaceuticals
- Appendix 4C - June 2019 Quarter
- Telix Receives $9.3m R&D Tax Refund
- Investor Presentation
- Telix announces completion of $40.0 million Placement
- Telix Reports Positive Phase III Meeting with the FDA
Later from Telix Pharmaceuticals
- Telix and Merck Group Combination Therapy Collaboration
- Telix and GenesisCare Commence Prostate Cancer Study
- Telix Pharmaceuticals announces results of successful SPP
- First Australian Patient Dosed in ZIRCON Phase III Trial
- Appendix 4D and Financial Report for half-year to 30 June 19
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals